Myocardial InfarctionDelay-MINCT07160556
Causes of Delayed Presentation of MI Patients to a Tertiary Care Hospital
An observational study of Myocardial Infarction and DM, run by Bacha Khan Medical College at 1 site in Pakistan.
Trial summary
This study is being done to learn more about people who have had a heart attack, also called a myocardial infarction (MI). A heart attack happens when blood flow to the heart muscle is blocked, causing damage. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Myocardial Infarction, DM, HTN-Hypertension
- What is being tested?
- Observational
- How many people
- 362 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jul 2024to 1 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population consists of adult patients diagnosed with acute myocardial infarction (MI) admitted to the cardiology department. Eligible participants include both male and female patients who meet the clinical and diagnostic criteria for MI and provide informed consent
Who may be able to join
- Adults aged 18 years and older with a confirmed diagnosis of myocardial infarction (STEMI or NSTEMI).
- Ability to provide informed consent (or consent from a legally authorized representative if patient is incapacitated).
Who cannot join
- Severe comorbid illness (e.g., advanced cancer, end-stage renal or liver disease) that may limit survival or affect study outcomes.
- Inability to comply with follow-up requirements (e.g., cognitive impairment, lack of contact information, or unwillingness to participate)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Causes of Delayed Presentation of Patients With Myocardial Infarction to a Tertiary Care Hospital: A Cross-Sectional Study
This study is being done to learn more about people who have had a heart attack, also called a myocardial infarction (MI). A heart attack happens when blood flow to the heart muscle is blocked, causing damage. The purpose of this study is to better understand the causes of delayed presentation and effects of the factors that caused delayed presentation.
We will collect information about patients' medical history, treatments, and recovery after their heart attack. This information may include blood tests, heart imaging, medications, and lifestyle factors. By studying these patients, we hope to find patterns that can help doctors predict complications, improve treatment, and reduce the chance of another heart attack.
The results of this study may help health care providers give better care and guidance to patients and families living with heart disease.
- Conditions
- Myocardial Infarction, DM, HTN-Hypertension
- Being tested
- Observational
- Keywords
- Myocardial Infarction, Delayed presentation, Acute Coronary Syndrome, Cardiovascular Disease
- Medical subject headings
- Myocardial Infarction, Hypertension, Acute Coronary Syndrome, Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationalOther
no intervention was required for this cross sectional study
What is being measured
The primary outcome is the main question the study is designed to answer.
Number and percentage of MI patients identifying specific barriers (e.g., lack of awareness, distance, transport issues) for delayed hospital presentation, using a researcher-designed structured questionnaire.
Data will be collected using a structured and standardized questionnaire. The questionnaire includes:
- Sociodemographic data: age, gender, BMI, employment status, past history of MI, and comorbidities.
- Knowledge of MI symptoms and severity.
- Pre-hospital details: first medical contact, transportation, and time to hospital.
- In-hospital details: time to diagnosis and treatment.
Responses will be summarized as frequency and percentage distributions for categorical variables (e.g., gender, employment, comorbidities), and mean ± SD for continuous variables (e.g., age, BMI).
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Sep 2025
- Study start1 Jul 2024
- Primary completion1 Nov 2024
- Study completion1 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 362 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bacha Khan Medical College
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Malik Shayan Ali Khan, Bacha Khan Medical College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07160556
- Sponsor's protocol ID
- Ref no. 524 /BKMC
- Acronym
- Delay-MI
- Status last verified
- Aug 2025
- First submitted
- 23 Aug 2025
- Last updated
- 8 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Causes of Delayed Presentation of Patients With Myocardial Infarction to a Tertiary Care Hospital: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07160556
- Acronym / sponsor ID
- Delay-MI / Ref no. 524 /BKMC
- Conditions
- Myocardial Infarction, DM, HTN-Hypertension
- Keywords
- Myocardial Infarction, Delayed presentation, Acute Coronary Syndrome, Cardiovascular Disease
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 362 participants (actual)
- Lead sponsor
- Bacha Khan Medical CollegeUniversity, hospital or other
- Study start
- 1 Jul 2024 (actual)
- Primary completion
- 1 Nov 2024 (actual)
- Study completion
- 1 Nov 2024 (actual)
- First posted
- 8 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is being done to learn more about people who have had a heart attack, also called a myocardial infarction (MI). A heart attack happens when blood flow to the heart muscle is blocked, causing damage. The purpose of this study is to better understand the causes of delayed presentation and effects of the factors that caused delayed presentation.
We will collect information about patients' medical history, treatments, and recovery after their heart attack. This information may include blood tests, heart imaging, medications, and lifestyle factors. By studying these patients, we hope to find patterns that can help doctors predict complications, improve treatment, and reduce the chance of another heart attack.
The results of this study may help health care providers give better care and guidance to patients and families living with heart disease.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of adult patients diagnosed with acute myocardial infarction (MI) admitted to the cardiology department. Eligible participants include both male and female patients who meet the clinical and diagnostic criteria for MI and provide informed consent
Key inclusion criteria (2 listed)
- Adults aged 18 years and older with a confirmed diagnosis of myocardial infarction (STEMI or NSTEMI).
- Ability to provide informed consent (or consent from a legally authorized representative if patient is incapacitated).
Key exclusion criteria (2 listed)
- Severe comorbid illness (e.g., advanced cancer, end-stage renal or liver disease) that may limit survival or affect study outcomes.
- Inability to comply with follow-up requirements (e.g., cognitive impairment, lack of contact information, or unwillingness to participate)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Observationalno intervention was required for this cross sectional study | Other | – |
Primary outcome
Number and percentage of MI patients identifying specific barriers (e.g., lack of awareness, distance, transport issues) for delayed hospital presentation, using a researcher-designed structured questionnaire.
Time frame: 6 months
Data will be collected using a structured and standardized questionnaire. The questionnaire includes: 1. Sociodemographic data: age, gender, BMI, employment status, past history of MI, and comorbidities. 2. Knowledge of MI symptoms and severity. 3. Pre-hospital details: first medical contact, transportation, and time to hospital. 4. In-hospital details: time to diagnosis and treatment. Responses will be summarized as frequency and percentage distributions for categorical variables (e.g., gender, employment, comorbidities), and mean ± SD for continuous variables (e.g., age, BMI).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Myocardial Infarction
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myocardial Infarction and DM, run by Bacha Khan Medical College at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number and percentage of MI patients identifying specific barriers (e.g., lack of awareness, distance, transport issues) for delayed hospital presentation, using a researcher-designed structured questionnaire. (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.